68 reports

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Depression
  • United States
  • World
  • Demand
  • Product Initiative

Global Depression Epidemiology and Patient Flow Analysis - 2016 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Bipolar Disorder (Manic Depression) - Epidemiology Forecast to 2027 ##.

  • Depression
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • Bipolar Disorder
  • Depression
  • Mental Health
  • United States
  • Market Shares
  • TYPES OF DEPRESSION
  • CAUSES & SYMPTOMS OF DEPRESSION

Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to...

  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.
  • related to depression and other mental disorders.
  • According to WHO, depression is the leading cause of disability in

Executive Summary A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents,...

  • Depression
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Depression
  • Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. It is also used to treat depression problems.

About Lifestyle Drugs Market Lifestyle disease is associated with the way an individual or group of people live. Some of the lifestyle diseases include depression, sexual dysfunction, anti-aging, baldness, and obesity. Technavio’s analysts forecast the global lifestyle drugs market to grow at a CAGR of 2.87% during the...

  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Physician Views: Can Lundbeck and Otsuka' s newly approved Rexulti compete with branded and generic competition in the schizophrenia and depression markets?

  • Depression
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • United States

Global Depressive Disorder Market DataPack (2016-2020) Types of Depression Causes & Symptoms of Depression Global Depressive Disorder Market by Value (2010-2015) Global Depressive Disorder Market Forecast by Value (2016-2020) Global Depressive Disorder Market by Region (2015) G

  • Antipsychotic
  • Depression
  • Therapy
  • World
  • Forecast
  • SUBTYPES OF MAJOR DEPRESSIVE DISORDER
  • PRESENTS THE DISEASE MANAGEMENT MODEL FOR MDD.

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. Similar to other neuropsychiatric disorders, MDD has a multifaceted and varied etiology, and remains poorly understood. The MDD...

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • 07. Disorder Overview
  • 06. Introduction

About depression drugs According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness,...

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 07.1 TYPES OF DEPRESSION
  • 07.4 TREATMENT AND MANAGEMENT

About Depression According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness,...

  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Depression
  • GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION SCREENING TESTS, BY REGION,

Introduction Depression and mental health are the leading cause of disability and ill health across the globe. According to the latest estimations from (World Health Organization) WHO, more than 300 million people are now living having depression with an increase of more than 18% between 2005 and 2015. Depression is a kind of mental condition...

  • Depression
  • North America
  • United States
  • World
  • Demand

It is a very common condition that affects ## in every ## Americans.

  • Antidepressant
  • Depression
  • Mental Health
  • Therapy
  • Market Size
  • BIPOLAR DISORDER (MANIC DEPRESSION)
  • Disorder and Treatment Resistant Depression

Depression - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H1 2018, provides an overview of the Depression (Central Nervous System) pipeline landscape. Depression is a mood disorder that causes...

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Depression - Discontinued Products
  • (MDD) and postpartum depression (PPD).

Depression - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H2 2017, provides an overview of the Depression (Central Nervous System) pipeline landscape. Depression is a mood disorder that causes a persistent feeling...

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION
  • LIBRA DEEP BRAIN STIMULATION SYSTEM - DEPRESSION - DEEP BRAIN STIMULATION FOR TREATMENT-RESISTANT DEPRESSION

Summary St. Jude Medical, Inc. (SJM) is a medical device company. It develops and manufactures devices for the cardiac rhythm management, cardiovascular, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation devices for the management of chronic pain. Its major products includes tachycardia implantable...

  • Depression
  • United States
  • GlobalData's company
  • Jude Medical, Inc.
  • Thoratec Corporation
  • 3.1 BIBLIOGRAPHY
  • PREVALENCE OF THE MOST FREQUENT PSYCHIATRIC COMORBIDITIES IN INDIVIDUALS WITH AND WITHOUT

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2025 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as a mood disorder that may lead to a variety of emotional and physical problems (Mayo Clinic, 2015). MDD is characterized by...

  • Depression
  • Japan
  • United States
  • World
  • Forecast
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • Latest Clinical Trials News on Bipolar Disorder (Manic Depression)

Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Bipolar Disorder (Manic Depression) Global Clinical Trials Review, H1, 2017" provides an overview of Bipolar Disorder (Manic Depression) clinical trials scenario. This report provides top line data relating...

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • Treatment Resistant Depression - Product Development Milestones
  • Treatment Resistant Depression - Discontinued Products, H2 2016

Treatment Resistant Depression - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Treatment Resistant Depression - Pipeline Review, H2 2016, provides an overview of the Treatment Resistant Depression (Central Nervous System) pipeline landscape. Treatment...

  • Depression
  • United States
  • Company Operations
  • Product Initiative
  • Avanir Pharmaceuticals, Inc.
  • Treatment Resistant Depression - Product Development Milestones
  • Treatment Resistant Depression - Discontinued Products, H1 2016

Treatment Resistant Depression - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Treatment Resistant Depression - Pipeline Review, H1 2016’, provides an overview of the Treatment Resistant Depression pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Depression
  • United States
  • Company Operations
  • Product Initiative
  • Avanir Pharmaceuticals, Inc.
  • Bipolar Disorder (Manic Depression) Overview
  • Bipolar Disorder (Manic Depression) - Recent Pipeline Updates

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2016’, provides an overview of the Bipolar Disorder (Manic Depression) pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Bipolar Disorder
  • Depression
  • Research And Development
  • United States
  • Company Operations
  • Official Title
  • Clinical Trial profile. 20 Trial Title

Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Post Partum Depression (Maternal Depression / Postnatal Depression) Global Clinical Trials Review, H2, 2015" provides an overview of Post Partum Depression (Maternal...

  • Depression
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Treatment Resistant Depression Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs,
  • Clinical Trial profile. 68 Trial Title

Treatment Resistant Depression Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Treatment Resistant Depression Global Clinical Trials Review, H2, 2015" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to the...

  • Clinical Trial
  • Depression
  • Pharmaceutical
  • World
  • Product Initiative